투자판단관련주요경영사항(임상시험계획승인신청) (Idtrexed(CT900) 기반 항암 치료제의 제2상 임상시험계획 승인신청(IND))[코]
Received: 3/10/2026 · Reporter: 킵스파마
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 24 filings
- Same category
- 13 filings
- Previous same-category filing
- 6/2/2026
- Corrections / withdrawals
- 3 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).